French Pleodrug for Rare Neurological Disease opens up phase III trial in US
Based in Paris (France), Pharnext is developing new therapies for neurological conditions, including rare diseases such as Charcot-Marie-Tooth Disease. Pharnext uses network pharmacology to discover synergistic combinations of drugs (Pleodrugs) that ...
Labiotech.eu (blog) - Wed, 27 Apr 2016 03:23



Medical College of Georgia doctors look at new antibodies in muscle weakness ...
Finally, at Augusta University Medical Center, she was diagnosed in 2014 as having myasthenia gravis, a disease where her own antibodies attack key receptors needed for proper functioning of voluntary muscles. But Benton is still part of ... Those two ...
The Augusta Chronicle - Sat, 02 Apr 2016 12:52



'Person-on-a-chip': Engineers grow 3-D heart, liver tissues for better drug ...
"They don't capture all the functional hallmarks of a real heart muscle, for example." A more realistic platform ... In future, Radisic envisions her lab-grown tissues being implanted into the body to repair organs damaged by disease. Because the cells ...
Science Daily - Mon, 07 Mar 2016 10:48



Identification of a novel agrin-dependent pathway in cell signaling and ...
Agrin is an extracellular matrix protein belonging to the heterogeneous family of heparan sulfate proteoglycans. Its best-characterized role is in the development of the neuromuscular junction during embryogenesis where it is expressed by motor neurons ...
Nature.com - Fri, 18 Mar 2016 08:32



Researchers Identify New Rare Neuromuscular Disease
There are a number of disorders – both acquired and inherited – that interfere with the communication that occurs at the neuromuscular junction. For example, in Lambert-Eaton myasthenic syndrome, which is most commonly triggered by certain cancers, the ...
University of Rochester Newsroom - Thu, 04 Sep 2014 08:56

Rare Neuromuscular Disease Identified In American And British Family; Genetic ...
Medical Daily - Thu, 04 Sep 2014 09:08

New drug to treat muscle wasting disease inclusion body myositis (IBM ...
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at ...
Medical Xpress - Wed, 23 Mar 2016 11:03



York leaders raise 'bail' money
Business and civic leaders from the York area took on roles as “jailbirds” and went behind bars Thursday for the Muscular Dystrophy Association's 2016 Lock-Up fundraiser in support of families battling various muscular diseases. The fundraiser took ...
York Daily Record/Sunday News - Thu, 24 Mar 2016 13:38

Researchers resolve longstanding issue of components needed to regenerate muscle
The discovery clears up deep-rooted conflicting data and will now help streamline efforts towards boosting stem cell-mediated muscle regeneration. Such strategies could treat muscle degenerative diseases such as muscular dystrophies, and those ...
Science Daily - Wed, 10 Feb 2016 08:24


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.